Drug Name: Depemokimab-ulaa

Brand Name: EXDENSUR®

Medicine Use: Add-on therapy/long-term control

Type of Medicine: Biologic

Form: Injection

Prescribing Info: EXDENSUR (depemokimab-ulaa) injection prescribing information insert

Note: EXDENSUR is the first ultra-long-acting biologic approved for asthma. While most biologics are given every 2 to 4 weeks, EXDENSUR is given only twice a year (once every 6 months).

Possible Side Effects:
Allergic reaction
Upper respiratory tract infection (common cold, sinus infection)
Sneezing, nasal congestion, runny nose, and nasal itching (allergic rhinitis)
Flu or flu-like symptoms
Joint pain
Sore throat

Copay Assistance Programs for EXDENSUR

If you have commercial insurance: If you have a commercial medical or prescription insurance plan, you may be able to take part on the EXDENSUR Copay Program. If you are approved, the GSK Copay Program may help with your cost share for EXDENSUR, as well as provide access to ongoing patient support from a Patient Navigator.

If you have government insurance or no insurance: You are not eligible for this program if you are covered by any federal or state prescription insurance program.

For more information, visit the EXDENSUR Copay Program website or call 888-216-3003.

Coverage Support

GSK can help check your insurance coverage and help you understand your benefits. You can reach out to a Patient Navigator at 844-225-5894 (844-Call-TwGSK).